Genetic News

A combination therapy of gemcitabine, capecitabine and bevacizumab improves outcomes in patients with advanced pancreatic cancer, according to a multi-center study led by researchers at Roswell Park Cancer Institute in Buffalo, N.Y. Read the rest of this entry »

Colon cancer patients who have the normal version of a particular gene are more likely to benefit from a combination treatment that includes adding the targeted therapy Erbitux to chemotherapy. Read the rest of this entry »

Chemotherapy may be more effective on melanoma tumors if a protein frequently found in the growth can first be disabled, a new study reports. Read the rest of this entry »

The long-awaited results of a trial of the biologic drug Erbitux on patients with advanced non-small cell lung cancer show it prolonged survival by about five weeks when combined with chemotherapy. Read the rest of this entry »

Adding the drug Avastin to chemotherapy lengthened progression-free survival in women with advanced breast cancer, new research shows. Read the rest of this entry »

Chemotherapy may reduce fertility in breast cancer survivors, according to a study led by researchers at Boston’s Dana-Farber Cancer Institute. Read the rest of this entry »

A panel of 15 genes may help determine which patients with early-stage non-small cell lung cancer will experience a recurrence and, therefore, benefit the most from chemotherapy, a new study shows. Read the rest of this entry »